[1]
G. Weiss, K. Lewandowski, J. Oneall, and S. Kroll, “Resolution of Cullen’s sign in patient with metastatic melanoma responding to hypoxia-activated prodrug TH-302”, DR, vol. 3, no. 3, p. e56, Dec. 2011.